Preoperative pembrolizumab (pembro) before radical cystectomy (RC) for muscle-invasive urothelial bladder carcinoma (MIUC): Interim clinical and biomarker findings from the phase 2 PURE-01 study.
2018 ◽
Vol 36
(15_suppl)
◽
pp. 4507-4507
◽
Keyword(s):
Phase 2
◽